Dallin Tavoian

Dallin is a clinical scientist with a PhD in Translational Biomedical Sciences from Ohio University and postdoctoral training from the University of Arizona. He has managed clinical trials that have tested novel treatments for neuromuscular disease, type 2 diabetes, sarcopenia, obstructive sleep apnea, hypertension, and cardiovascular disease. Dallin is the Clinical Operations Manager for the RECOVER observational study, which is focused on understanding the complexities of long COVID to identify potential treatment options and improve patient outcomes. He is also a member of the Clinical and Translational Sciences Advisory Committee at the University of Arizona.